{"Clinical Trial ID": "NCT00768222", "Intervention": ["INTERVENTION 1:", "Chinese silk suture", "Natural, non-absorbent silk suture, of silkworm larva yarn, commercially available in China, used in a simple pattern of interrupted transdermal suture", "INTERVENTION 2:", "VICRYL* Plus suture", "- Synthetic absorbent surgical suture consisting of a copolymer of 90% glycolide and 10% L-lactide containing an antibacterial triclosan, used in a subcutaneous closure technique"], "Eligibility": ["Incorporation criteria:", "18 years of age or older with informed written consent", "\u2022 Planned for a modified radical mastectomy", "- Class of Surgery Injury Class I/Clean using the CDC SSI Surgical Wound Classification", "- Exclusion criteria:", "Unable to give consent and unlikely to comply with the requirements of the study and complete the 90-day follow-up visit", "Current surgery for a radical modified mastectomy with immediate breast reconstruction, cosmetic breast operations, reduction, expansion, insertion of prostheses, canal ectasia or infectious breast disease or implant", "\u2022 Surgery injuries classified in classes II, III or IV according to the classification of SSI CDC surgical injuries", "Inflammatory cancers or skin ulceration", "Has experienced an allergy or intolerance to triclosan", "has compromised wound healing or chronic immune deficiency, e.g. diabetes, prolonged steroid use, AIDS or substance abuse", "A serious heart and/or lung disease", "Has a history of skin scars or family history", "\u00b7 Has a direct connection with or participation in this study or other studies under the direction of the investigator or centre", "Has received a drug or an experimental device within 30 days of the expected start of treatment"], "Results": ["Performance measures:", "Average score on the visual analogue scale of cosmetic results (VAS)", "The post-operative cosmetic results evaluated on surgical site photographs by an independent blinded central assessor using a validated 100 mm visual analog scale, with 0 representing the worst possible scar and 100 representing the best possible scar", "Duration: 30 days (+/- 5) after the operation", "Results 1:", "Title of the arm/group: Chinese silk suture", "Description of the arm/group: Natural non-absorbent silk suture in silkworm larva yarn, commercially available in China, used in a simple pattern of interrupted transdermal suture", "Total number of participants analysed: 50", "Average (standard deviation)", "Unit of measure: scale score 45.4 (12.0)", "Results 2:", "Title of the arm/group : VICRYL* Plus suture", "Description of the arm/group: Synthetic absorbent surgical suture consisting of a copolymer of 90% glycol and 10% L-lactide containing an antibacterial triclosan, used in a subcutaneous closure technique", "Total number of participants analysed: 51", "Average (standard deviation)", "Unit of measurement: scale score 67.2 (18.2)"], "Adverse Events": ["Undesirable Events 1:", "Total: 3/50 (6.0%)", "- Skin lymphangitis 1/50 (2.0%)", "Bone marrow suppression 0/50 (0.00 %)", "- Allergic shock 1/50 (2.0%)", "SSI 1/50 deep incisional (2.0%)", "Adverse Events 2:", "Total: 1/51 (1.96%)", "- Skin lymphangitis 0/51 (0.00 %)", "Bone marrow suppression 1/51 (1.96%)", "- Allergic shock 0/51 (0.00 %)", "SSI 0/51 deep incisional (0.00 %)"]}